Treatment Duration for Viral Encephalitis
For confirmed HSV encephalitis, treat with intravenous acyclovir for 14-21 days, and perform a repeat lumbar puncture at the end of treatment to confirm CSF HSV PCR negativity; if still positive, continue IV acyclovir with weekly PCR monitoring until negative. 1
HSV Encephalitis: The Primary Concern
The treatment duration evolved from the original 10-day regimen used in early acyclovir trials because clinical relapses were documented after shorter courses 1. While some relapses are immune-mediated, evidence shows continuing viral replication in certain cases, justifying the extended duration 1.
Standard Treatment Protocol
- Adults and children with normal renal function: Acyclovir 10 mg/kg IV every 8 hours for 14-21 days 2
- Neonates: Acyclovir 20 mg/kg IV every 8 hours for 21 days (this higher dose reduced mortality to 5% with ~40% of survivors developing normally) 2
Critical End-of-Treatment Assessment
Repeat CSF PCR at 14-21 days is essential 1. This step determines whether treatment can be safely stopped:
- If CSF PCR is negative: Stop acyclovir
- If CSF PCR remains positive: Continue IV acyclovir with weekly PCR testing until negative 1
A negative CSF PCR at end of therapy correlates with better outcomes 2. This approach is supported by European Consensus Statements and represents current best practice 1.
When to Stop Acyclovir Early
Acyclovir can be discontinued in immunocompetent patients if 1:
- An alternative diagnosis is established, OR
- HSV PCR in CSF is negative on two occasions 24-48 hours apart AND MRI is not characteristic for HSV encephalitis, OR
- HSV PCR in CSF is negative once >72 hours after neurological symptom onset, with unaltered consciousness, normal MRI (performed >72 hours after symptom onset), and CSF <5 × 10⁶/L white cells
Important Caveat on Early Negative PCR
Do not stop acyclovir based on a single negative CSF PCR alone when HSV encephalitis remains clinically suspected 1. Initial CSF PCR can be falsely negative if obtained <72 hours after symptom onset or late in illness after viral clearance 1. In patients with ongoing altered consciousness, CSF pleocytosis, or imaging abnormalities despite negative initial PCR, repeat CSF examination after 24-48 hours 1.
Other Viral Encephalitides
For non-HSV viral encephalitis (VZV, CMV, enteroviruses), specific treatment durations are less well-established 2. The IDSA guidelines provide pathogen-specific recommendations, but most lack the robust evidence base that exists for HSV 2.
- VZV encephalitis: Acyclovir may be effective, though evidence is limited to case reports 2
- CMV encephalitis: Ganciclovir 5 mg/kg IV every 12 hours, though optimal duration is not clearly defined 2
Monitoring and Safety
Monitor renal function closely - acyclovir causes reversible nephropathy through crystalluria in up to 20% of patients, typically manifesting after 4 days of IV therapy 1. Ensure adequate hydration and dose adjustment for renal impairment.
Role of Oral Valacyclovir
While oral acyclovir does not achieve adequate CSF levels, valacyclovir (its valine ester with good oral bioavailability) may have a role in ongoing treatment, particularly when HSV remains detectable in CSF after 2-3 weeks 1. This is primarily used in pediatrics when IV access is difficult, but remains investigational in adults 1.
Prognostic Factors
Earlier treatment initiation dramatically improves outcomes. Mortality decreased to 8% when acyclovir was started <4 days after symptom onset, compared to 28% overall mortality at 18 months 2. Delays of ≥2 days between hospital admission and acyclovir administration independently predict poor outcomes 2.